IP Library › Granted Patent US 11,357,651
Granted Patent B2
US 11,357,651 · App. 15/559,755 · Granted Jun 14, 2022

Stent assembly and method of preparing the stent assembly

Inventors: Subramaniam Venkatraman (Singapore, SG); Yingying Huang (Singapore, SG); Wei Shan Lim (Singapore, SG); Tsung Wen Chong (Singapore, SG)
Assignees: Nanyang Technological University; Singapore Health Services Pte. Ltd.
A61F2/94A61F2/04A61K31/337A61K31/407A61K31/505A61L31/10A61L31/145A61L31/148A61L31/16A61F2002/048A61F2210/0004A61F2210/0061A61F2210/0071A61F2240/001A61F2250/0067A61L2300/416A61L2420/02A61L2420/06A61M27/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,357,651
App. No.
15/559,755
Granted
Jun 14, 2022
Kind
B2
Abstract

Various embodiments relate to a stent assembly comprising a stent; a swellable coating disposed on at least a portion of an exterior surface of the stent; optionally, a carrier dispersed in the swellable coating and/or disposed on at least a portion of an exterior surface of the stent; and an active agent comprised in at least one of the swellable coating or the carrier, if present. Use of the stent assembly as a ureteric stent, and method of preparing a stent assembly are also provided.

Claims (22)

1. A stent assembly consisting of:

a stent, wherein the stent is a tube or a helical coil;

a first carrier comprising a first active agent, wherein the first carrier is disposed as one or more layers on at least a portion of an exterior surface of the stent; and

a swellable coating comprising a second active agent, wherein the swellable coating further comprises a second carrier comprising a third active agent, wherein the second carrier is in a form of particles, wherein the swellable coating is disposed on at least a portion of the one or more layers of the first carrier, wherein the swellable coating swells by 5 times to 160 times its volume under urinary conditions to make contact with a ureter wall of a subject.

2. The stent assembly according to claim 1 , wherein the swellable coating comprises a swellable material selected from the group consisting of a hydrogel, a water swellable polymer, a superabsorbent polymer, copolymers of the water swellable polymer and the superabsorbent polymer, and combinations thereof.

3. The stent assembly according to claim 1 , wherein the first, second and third active agents are independently selected from the group consisting of an antifibrotic agent, an anticancer agent, a discomfort reducing agent, an antibacterial agent, a gene, a gene vector, a growth factor, and combinations thereof.

4. The stent assembly according to claim 1 , wherein amount of the first active agent in the first carrier is in the range of about 2 wt % to about 25 wt % of the carrier.

5. The stent assembly according to claim 1 , wherein the one or more layers has a thickness in the range of about 10 μm to about 1000 μm.

6. The stent assembly according to claim 1 , wherein the one or more layers comprises a thermoplastic elastomer.

7. A method of preparing a stent assembly of claim 1 , the method comprising:

providing a stent, wherein the stent is a tube or a helical coil;

disposing a swellable coating on the stent, wherein the swellable coating is adapted to swell by 5 times to 160 times its volume under urinary conditions to make contact with a ureter wall of a subject; and

disposing a first carrier on at least a portion of an exterior surface of the stent,

wherein the first carrier comprises a first active agent, and

wherein the swellable coating comprises a swellable material and a second active agent, the swellable coating further comprises a second carrier comprising a third active agent, the second carrier being in a form of particles.

8. The method according to claim 7 , wherein providing the stent comprises physically treating the exterior surface of the stent by etching, and/or roughening the exterior surface with solid particles.

9. The method according to claim 7 , wherein providing the stent comprises chemically treating the exterior surface of the stent with plasma treatment.

10. The method according to claim 7 , wherein disposing the swellable coating on the stent comprises applying a liquid reagent comprising the swellable material and the second active agent on at least the portion of the exterior surface of the stent.

11. The method according to claim 7 , wherein disposing the first carrier comprises dispersing the first carrier on the exterior surface of the stent.

12. The method according to claim 7 , wherein the swellable material comprises a hydrogel.

13. The method according to claim 12 , wherein disposing the swellable coating on the stent further comprises cross-linking a hydrogel-forming agent to form the hydrogel.

14. The method according to claim 13 , wherein the swellable material further comprises a photoinitiator.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: CHONG, TSUNG WEN
To: SINGAPORE HEALTH SERVICES PTE. LTD.
Reel/Frame 044377/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: VENKATRAMAN, SUBRAMANIAM; HUANG, YINGYING; LIM, WEI SHAN
To: NANYANG TECHNOLOGICAL UNIVERSITY
Reel/Frame 044377/0429 →
Priority Claims (1)
SG 10201502162X · Mar 19, 2015 · national
Continuity (1)
Related Publication 20180042742A1 · Feb 15, 2018
Cited By (1)
US 12,193,956